Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marx

Showing results (261-270 of 365) with videos related to

Pageof 37
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depressionE Sherwood Brown, John Park, Christine E Marx, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Healthcare resource utilization in Hepatitis C-infected patients completing eight versus twelve weeks of treatment: A retrospective cohort studyKatia E Valdez, Marjan Javanbakht, Kori Keith, et al.
Neuroscience Letters|February 21, 2017
Neuroactive steroids and PTSD treatmentAnn M Rasmusson, Christine E Marx, Suzanne L Pineles, et al.
Journal of Hospital Medicine|February 9, 2026
Incidence, contributing factors, and predictors of diagnostic errors in medical inpatients: A retrospective cohort studyCaterina E Marx, Elena Hofmann, Martin Perrig, et al.
The American Journal of Psychiatry|January 29, 2005
Neuroactive steroids and suicidality in posttraumatic stress disorderMarian I Butterfield, Karen M Stechuchak, Kathryn M Connor, et al.
Open Forum Infectious Diseases|July 26, 2019
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP CareKevin F Kamis, Grace E Marx, Kenneth A Scott, et al.
Emerging Infectious Diseases|January 22, 2026
Nonspecific Symptoms Attributable to Lyme Disease in High-Incidence Areas, United States, 2017-2021Courtney C Nawrocki, Mark J Delorey, Austin R Earley, et al.
Neuroscience|July 16, 2011
Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidenceC E Marx, D W Bradford, R M Hamer, et al.
Public Health Reports (Washington, D.C. : 1974)|December 29, 2023
Considerations for Defining Homelessness in Public Health Data CollectionAshley A Meehan, Caroline J Waddell, Grace E Marx, et al.
Vaccine|August 17, 2023
Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022Thomas D Filardo, Namrata Prasad, Caroline J Waddell, et al.
Pageof 37

Showing results (261-270 of 365) with videos related to

Sort By:
Pageof 37
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depressionE Sherwood Brown, John Park, Christine E Marx, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Healthcare resource utilization in Hepatitis C-infected patients completing eight versus twelve weeks of treatment: A retrospective cohort studyKatia E Valdez, Marjan Javanbakht, Kori Keith, et al.
Neuroscience Letters|February 21, 2017
Neuroactive steroids and PTSD treatmentAnn M Rasmusson, Christine E Marx, Suzanne L Pineles, et al.
Journal of Hospital Medicine|February 9, 2026
Incidence, contributing factors, and predictors of diagnostic errors in medical inpatients: A retrospective cohort studyCaterina E Marx, Elena Hofmann, Martin Perrig, et al.
The American Journal of Psychiatry|January 29, 2005
Neuroactive steroids and suicidality in posttraumatic stress disorderMarian I Butterfield, Karen M Stechuchak, Kathryn M Connor, et al.
Open Forum Infectious Diseases|July 26, 2019
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP CareKevin F Kamis, Grace E Marx, Kenneth A Scott, et al.
Emerging Infectious Diseases|January 22, 2026
Nonspecific Symptoms Attributable to Lyme Disease in High-Incidence Areas, United States, 2017-2021Courtney C Nawrocki, Mark J Delorey, Austin R Earley, et al.
Neuroscience|July 16, 2011
Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidenceC E Marx, D W Bradford, R M Hamer, et al.
Public Health Reports (Washington, D.C. : 1974)|December 29, 2023
Considerations for Defining Homelessness in Public Health Data CollectionAshley A Meehan, Caroline J Waddell, Grace E Marx, et al.
Vaccine|August 17, 2023
Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022Thomas D Filardo, Namrata Prasad, Caroline J Waddell, et al.
Pageof 37